These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 537929)

  • 1. [Evaluation of the effectiveness of radiotherapy of supraglottic laryngeal cancer in cases of clinically unchanged cervical lymph nodes].
    Skołyszewski J
    Nowotwory; 1979; 29(4):275-80. PubMed ID: 537929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cervical metastatic lymphnodes in laryngeal cancer patients following radiotherapy].
    Kozuch-Gdak W; Peszyński J; Kukolewska-Machnicka J; Gliński B; Orzelski L
    Otolaryngol Pol; 1994; 48(2):146-51. PubMed ID: 8028905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy of primary tumors and lymph nodes N1-N3].
    Cosentino D
    Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():81-6. PubMed ID: 1927511
    [No Abstract]   [Full Text] [Related]  

  • 4. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
    Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
    Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
    Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
    Clark CH; Bidmead AM; Mubata CD; Harrington KJ; Nutting CM
    Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of No lymph nodes in laryngeal tumors, stages I and II].
    Margarino G; Scala M; Mereu P; Schenone G; Adami M; Galli A
    Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():53-8. PubMed ID: 1927507
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of pre-operative radiotherapy for supraglottic larynx cancer.
    Hendrickson FR; Liebner E
    Ann Otol Rhinol Laryngol; 1968 Apr; 77(2):222-9. PubMed ID: 4967479
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.
    Maciejewski B; Taylor JM; Withers HR
    Radiother Oncol; 1986 Dec; 7(4):323-6. PubMed ID: 3809591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical indications for laryngectomy in the patients with carcinoma of the larynx after failed radiotherapy].
    Jordan J; Piotrowski S
    Otolaryngol Pol; 1994; 48(3):266-74. PubMed ID: 8090490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exclusive radical radiotherapy of laryngeal tumors: 10-year experience].
    Basilico L; Taraborrelli M; Laudadio L; Nuzzo A; Basilico NF; Peretti G; D'Alessandro M; Neri G; Croce A
    Radiol Med; 1997; 94(1-2):90-3. PubMed ID: 9424659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of electron pendulum irradiation to cervical lymph nodes].
    Poser H; Németh G; Kuttig H
    Strahlentherapie; 1973 Mar; 145(3):277-81. PubMed ID: 4633315
    [No Abstract]   [Full Text] [Related]  

  • 13. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation of clinically uninvolved cervical lymph nodes.
    Goffinet DR; Gilbert EH; Weller SA; Bagshaw MA
    Can J Otolaryngol; 1975; 4(5):927-33. PubMed ID: 812601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exclusive radiotherapy in 250 cases of stage I-II cancers of the supraglottic larynx].
    Glínski B; Reinfuss M; Walasek T; Skolyszewski J
    Bull Cancer Radiother; 1996; 83(3):177-9. PubMed ID: 8977571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgery of lymph nodes N1-N3: conservative or radical dissection].
    Antonelli AR; Nicolai P; Redaelli de Zinis LO; Luzzago F; Moretti R
    Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():69-79. PubMed ID: 1927509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of radiotherapy in patients with advanced laryngeal cancer after total excision of the larynx].
    Stryjewska B; Korzeniowski S
    Nowotwory; 1986; 36(4):312-9. PubMed ID: 3601686
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiotherapy of laryngeal cancer. General principles and results in T1 and T2 cases.
    De Schryver A
    Acta Otorhinolaryngol Belg; 1992; 46(2):187-95. PubMed ID: 1605021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of postradiotherapy neck dissection in supraglottic carcinoma.
    Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns and prognostic factors of cervical lymph node metastasis in supraglottic laryngeal carcinoma].
    Li X; Di B; Shao Y; Shang Y; Cheng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):707-10. PubMed ID: 15831037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.